We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Toshiba Announces PET Distribution Agreement

By HospiMedica staff writers
Posted on 11 Nov 2003
Under the terms of a distribution agreement, Toshiba Medical Systems Corp. (Tokyo, Japan; www.toshiba.com) will distribute in Japan certain positron emission tomography (PET) products of CPS Innovations, the trade name for CTI Systems, Inc., a joint venture of CTI Molecular Imaging, Inc. (Knoxville, TN, USA) and Siemens Medical Solutions USA, Inc. (Malvern, PA, USA).

The PET systems to be distributed by Toshiba will feature the LSO FastPET technology of CPS and will be supported by Toshiba's customer service force. This technology allows for much faster scanning times than predecessor technologies and is well suited for clinical applications in Japan, because its physical characteristics maximize image quality at the lowest possible dose level.

"We will be able to provide our customers in Japan with the highest diagnostic performance by combining the CPS PET systems and our specialized applications technology cultivated with our SPECT technology,” said Kenichiro Katsumata, senior vice president, Toshiba Medical Systems Corp.





Related Links:
Toshiba Med. Systems
CTI
Siemens Med. Solutions USA
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
12-Channel ECG
CM1200B
X-Ray Generator
Advantage Plus Generators
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel

Channels

Artificial Intelligence

view channel
Image: Coredio’s CPSE is a a software-as-a-medical-device platform designed for use with consumer smartwatches and standard blood pressure cuffs in clinical and home settings under physician supervision (Photo courtesy of Coredio)

AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure

Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read more